Tuberculosis (TB) and HIV cause significant suffering in Europe. It is estimated that 27,000 patients have both diseases. The distribution of co-infected patients is heterogeneous in Europe. Collaborative activities are needed to take the best care of those with TB/HIV co-infection. This is the background information of the survey on collaborative TB/HIV activities in countries of the WHO European Region created by the Wolfheze working group on collaborative TB/HIV activities.
The Wolfheze group documents and promotes the best models and identifies research priorities of integrated TB/HIV care in the European region. Members of the group also identify barriers in TB/HIV services and collaboration. AFEW’s executive director Anke van Dam is the chair of Wolfheze Working Group on TB/HIV collaborative activities.
What this survey adds:
• All countries have guidelines for management of TB/HIV co-infection.
• Models of care for TB/HIV co-infection differ between countries.
• Collaborative TB/HIV activities as recommended by WHO are not universally implemented.
The full version of the survey is available here.
